Cargando…

Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson’s disease: mitochondrial DNA integrity

INTRODUCTION: In Parkinson’s disease (PD), compelling data indicate a functional link between adenosine/dopamine receptors and the progression of the neurodegenerative process. The present study was carried out to evaluate the effect of the non-selective adenosine receptor (ADR) antagonist caffeine,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Essawy, Soha S., Tawfik, Mona Kamal, Korayem, Horya Erfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Experimental Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420638/ https://www.ncbi.nlm.nih.gov/pubmed/28507584 http://dx.doi.org/10.5114/aoms.2017.67284

Ejemplares similares

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Effects of intravenous human umbilical cord blood CD34+ stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice
por: Abo-Grisha, Noha, et al.
Publicado: (2013)

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress
por: Paul, Rajib, et al.
Publicado: (2017)

Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models
por: Kurtenbach, Stefan, et al.
Publicado: (2013)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson’s Disease
por: De Nuccio, Francesco, et al.
Publicado: (2021)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson’s disease
por: Geldenhuys, Werner J., et al.
Publicado: (2015)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu, Shanshan, et al.
Publicado: (2020)

“Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease”
por: Rodríguez-Cruz, Alfredo, et al.
Publicado: (2019)

MPTP-induced mouse model of Parkinson’s disease: A promising direction for therapeutic strategies
por: Mustapha, Musa, et al.
Publicado: (2021)

Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent
por: Aktas, Busra
Publicado: (2023)

Crocetin Alleviates Inflammation in MPTP-Induced Parkinson's Disease Models through Improving Mitochondrial Functions
por: Dong, Na, et al.
Publicado: (2020)

Expression analysis of genes involved in mitochondrial biogenesis in mice with MPTP-induced model of Parkinson's disease
por: Rudenok, M.M., et al.
Publicado: (2020)

Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
por: Lu, Ming, et al.
Publicado: (2016)

Effects of treadmill exercise on hippocampal neurogenesis in an MPTP /probenecid-induced Parkinson’s disease mouse model
por: Sung, Yun-Hee
Publicado: (2015)

Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease
por: Lauretti, E, et al.
Publicado: (2016)

(−)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
por: Zhou, Tingting, et al.
Publicado: (2018)

Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
por: Ribeiro-Carvalho, A., et al.
Publicado: (2021)

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
por: Li, Tiantian, et al.
Publicado: (2022)

Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse
por: Heng, Yang, et al.
Publicado: (2022)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades
por: Tawfik, Mona Kamal
Publicado: (2016)

Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
por: Gołembiowska, Krystyna, et al.
Publicado: (2013)

The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022)

Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
por: Barber-Singh, Jennifer, et al.
Publicado: (2010)

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
por: Noelker, Carmen, et al.
Publicado: (2013)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease
por: Martin, Heather L., et al.
Publicado: (2015)

Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2017)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
por: Zhao, Ting Ting, et al.
Publicado: (2017)

TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
por: Shao, Qian-hang, et al.
Publicado: (2019)

Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2021)

Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota
por: Zhou, Xiaoting, et al.
Publicado: (2021)

Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease
por: Parekh, Pathik, et al.
Publicado: (2022)

Neurochemical, histological, and behavioral profiling of the acute, sub‐acute, and chronic MPTP mouse model of Parkinsonʼs disease
por: Santoro, Matteo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d7hhtjk0j7gr2ref96n172lnse